BCEIE › News › AEQUS

M&A

Aequs: The receipt of order from Office of the Regional Director, South Western Region in respect of rejection of…

Aequs (AEQUS) filed a disclosure titled "The receipt of order from Office of the Regional Director, South Western Region in respect of rejection of the Scheme of Amalgamation between". The company is valued at about ₹18,343 crore.

BCEIE News Desk · Published 13 Oct 2026, 05:42 pm IST · Filing received 13 Oct 2026, 05:27 pm IST

What happened

Aequs (AEQUS) filed a disclosure with the exchanges on 13 October 2026 at 05:27 PM titled "The receipt of order from Office of the Regional Director, South Western Region in respect of rejection of the Scheme of Amalgamation between".

From the filing: "Aequs Limited has informed the Exchange about the receipt of order from Office of the Regional Director, South Western Region in respect of rejection of the Scheme of Amalgamation between ...."

Company snapshot

Aequs is a small-cap company in the Capital Goods sector, with a market value of about ₹18,343 crore.

The stock last traded at ₹273.5, against a 52-week range of ₹113.3–₹294.7 (7.2% below the high).

Before this filing the shares had moved +18.9% over the month and +12.8% over three months. Average daily turnover over the last 20 sessions was about ₹136 crore.

Promoters held 59.09% at the end of Q1 FY27, up 0.01% points from the previous quarter. Foreign institutions owned 5.16% and domestic institutions 8.85%.

Quarterly results (consolidated, ₹ crore)
QuarterRevenueNet profitEPS (₹)
Q3 FY26326-42.7-0.7
Q4 FY26367-53.7-0.8
Q1 FY27396-53.2-0.81

What history shows

This is not the company's first m&a disclosure: BCEIE has 1 earlier filing of this kind on record since May 2026.

Across 148 similar disclosures by other Capital Goods companies, shares moved −0.2% on average the next day and +0.1% over five days; 45% of them rose the next day.

Market-wide, 2,046 m&a filings with an impact score of 50 or more saw an average next-day move of +0.4%, with 49% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

  • Regulatory approvals, completion of the deal and its effect on revenue and margins.

In the news

Recent coverage elsewhere (links open the original publisher):

Source

Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.

More on Aequs Limited